BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22337081)

  • 1. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.
    Okabe H; Beppu T; Ueda M; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Mima K; Miyake K; Iwatsuki M; Baba Y; Takamori H; Jono H; Shinriki S; Ando Y; Baba H
    Int J Cancer; 2012 Nov; 131(10):2234-41. PubMed ID: 22337081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
    Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.
    Okabe H; Beppu T; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Jono H; Ueda M; Shinriki S; Ando Y; Baba H
    Ann Surg Oncol; 2011 Apr; 18(4):1175-84. PubMed ID: 21042948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL7 promotes proliferation and invasion of cholangiocarcinoma cells.
    Guo Q; Jian Z; Jia B; Chang L
    Oncol Rep; 2017 Feb; 37(2):1114-1122. PubMed ID: 27959418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway.
    Kuo PL; Chen YH; Chen TC; Shen KH; Hsu YL
    J Cell Physiol; 2011 May; 226(5):1224-31. PubMed ID: 20945384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma.
    Okabe H; Beppu T; Hayashi H; Horino K; Masuda T; Komori H; Ishikawa S; Watanabe M; Takamori H; Iyama K; Baba H
    Ann Surg Oncol; 2009 Sep; 16(9):2555-64. PubMed ID: 19548033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma.
    Kim Y; Kim MO; Shin JS; Park SH; Kim SB; Kim J; Park SC; Han CJ; Ryu JK; Yoon YB; Kim YT
    Ann Surg Oncol; 2014 Aug; 21(8):2684-98. PubMed ID: 24682719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells.
    Thongchot S; Ferraresi A; Vidoni C; Loilome W; Yongvanit P; Namwat N; Isidoro C
    Cancer Lett; 2018 Aug; 430():160-171. PubMed ID: 29802929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils.
    Zhou SL; Dai Z; Zhou ZJ; Chen Q; Wang Z; Xiao YS; Hu ZQ; Huang XY; Yang GH; Shi YH; Qiu SJ; Fan J; Zhou J
    Carcinogenesis; 2014 Mar; 35(3):597-605. PubMed ID: 24293410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.
    Ohira S; Sasaki M; Harada K; Sato Y; Zen Y; Isse K; Kozaka K; Ishikawa A; Oda K; Nimura Y; Nakanuma Y
    Am J Pathol; 2006 Apr; 168(4):1155-68. PubMed ID: 16565491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
    Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
    Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions.
    Massani M; Stecca T; Fabris L; Caratozzolo E; Ruffolo C; Furlanetto A; Morton S; Cadamuro M; Strazzabosco M; Bassi N
    Oncol Rep; 2013 Sep; 30(3):1143-8. PubMed ID: 23807641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.
    Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S
    Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines.
    Sirica AE; Zhang Z; Lai GH; Asano T; Shen XN; Ward DJ; Mahatme A; Dewitt JL
    Hepatology; 2008 Apr; 47(4):1178-90. PubMed ID: 18081149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma.
    Jeong CY; Hah YS; Cho BI; Lee SM; Joo YT; Jung EJ; Jeong SH; Lee YJ; Choi SK; Ha WS; Park ST; Hong SC
    Oncol Rep; 2012 Oct; 28(4):1283-92. PubMed ID: 22825302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
    Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
    Heits N; Heinze T; Bernsmeier A; Kerber J; Hauser C; Becker T; Kalthoff H; Egberts JH; Braun F
    BMC Cancer; 2016 May; 16():322. PubMed ID: 27206490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
    Janpipatkul K; Suksen K; Borwornpinyo S; Jearawiriyapaisarn N; Hongeng S; Piyachaturawat P; Chairoungdua A
    Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma.
    Ohira S; Itatsu K; Sasaki M; Harada K; Sato Y; Zen Y; Ishikawa A; Oda K; Nagasaka T; Nimura Y; Nakanuma Y
    Pathol Int; 2006 Jul; 56(7):381-9. PubMed ID: 16792547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.